| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |